Inventor · disambiguated record
Fai Jim
Also filed as: JIM FAI
0 granted patents·12 pending applications·0 citations·filing 2002–2020
Files withENDO PHARMACEUTICALS INC4ENDO PHARMACEUTICALS INC A DEL2KAO HUAI-HUNG2RELMADA THERAPEUTICS INC2
Top patents by PatentIndex Score
12 records- 0154US2013209561A1Abuse-resistant opioid dosage formENDO PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 0251US2012231075A1Abuse-resistant opioid dosage formKAO HUAI-HUNG·Filed 2012·Application pending·0 cites
- 0351US2012237603A1Abuse-resistant opioid dosage formKAO HUAI-HUNG·Filed 2012·Application pending·0 cites
- 0451US2005169990A1Controlled release dosage forms using acrylic polymer, and process for makingFiled 2004·Application pending·0 cites
- 0550US2007281017A1Sustained release oxycodone composition with acrylic polymer and metal hydroxideENDO PHARMACEUTICALS INC A DEL·Filed 2006·Application pending·0 cites
- 0650US2007281016A1Sustained release oxycodone composition with acrylic polymer and surfactantENDO PHARMACEUTICALS INC A DEL·Filed 2006·Application pending·0 cites
- 0750US2011135731A1Abuse-resistant opioid dosage formENDO PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
- 0849US2011020444A1Abuse-resistant opioid dosage formENDO PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 0946US2003004177A1Abuse-resistant opioid dosage formENDO PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 1046US2022105085A1Abrasion-resistant opioid formulations which resist abuse and include a sequestered opioid antagonistRELMADA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1140US2017326134A1Abrasion-Resistant Opioid FormulationsRELMADA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1222US2003092724A1Combination sustained release-immediate release oral dosage forms with an opioid analgesic and a non-opioid analgesicFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Fai Jim files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →